Real-time treatment zone predictor for electroporation
This technology is a software-based planning system that calculates the three-dimensional zone of tissue that will be affected when electrical energy is delivered through multiple electrodes during a medical procedure — such as irreversible electroporation (IRE) used in tumor ablation. It works by comparing the electrical conductivity of the target tissue during treatment against a baseline measurement, then uses that ratio in a numerical model to generate a visual map of the treatment volume on a display. The clinician sees, before or during the procedure, a predictive 3D shape showing how far the energy will penetrate and destroy tissue. This removes much of the guesswork in electrode placement and helps avoid under-treating tumors or damaging surrounding healthy structures.
What you could build
A treatment planning software module integrated into ablation system consoles — targeting interventional radiologists and oncology surgeons who perform IRE or similar electroporation-based tumor ablation procedures in hospitals and cancer centers.
Who in Virginia should care
Virginia-based hospital systems and cancer centers (Inova, VCU Health, UVA Health) performing interventional oncology procedures would be natural clinical validation partners or early adopters.
Readiness: Prototype likely
Concept — described but not yet demonstrated. Lab validated — supported by experimental results in the patent. Prototype likely — the text describes a built, working embodiment.
Readiness is inferred from the patent text, not from a lab visit.
The record
- Inventors
- —
- Granted
- November 12, 2019
- Status
- Granted patent
- Patent number
- 102810
Ready to talk?
Virginia Tech Intellectual Properties handles licensing for this technology. Email us for an introduction prosim@harbor.capital.
Prosim summaries are generated from public patent text and are not legal advice.